Hygeia Healthcare Holdings Valuation
Is 6078 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Share Price vs Fair Value
What is the Fair Price of 6078 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6078?
Other financial metrics that can be useful for relative valuation.
| What is 6078's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | n/a |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.8x |
| Enterprise Value/EBITDA | 10.9x |
| PEG Ratio | 0.7x |
Price to Earnings Ratio vs Peers
How does 6078's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 19.1x | ||
1515 China Resources Medical Holdings | 17.3x | 31.9% | HK$5.5b |
3309 C-MER Medical Holdings | 45x | n/a | HK$2.8b |
2219 Chaoju Eye Care Holdings | 8.7x | 19.2% | HK$2.0b |
1526 Rici Healthcare Holdings | 5.5x | n/a | HK$1.9b |
6078 Hygeia Healthcare Holdings | 15.1x | 21.7% | HK$12.0b |
Price to Earnings Ratio vs Industry
How does 6078's PE Ratio compare vs other companies in the HK Healthcare Industry?
Price to Earnings Ratio vs Fair Ratio
What is 6078's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 15.1x |
| Fair PE Ratio | 19.5x |
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?